STD and PID

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 42

Sexually Transmitted Diseases and

Pelvic Inflammatory Disease


Salih H. MD
Assistant Professor in Obstetrics and Gynecology
Addis Ababa University
Outline
• Introduction
• Epidemiology
• Classification of STDs
• Clinical diagnosis and evaluation
• Prevention and control of STDs
• Management approaches for STDs
• Pelvic inflammatory disease
Introduction
• A variety of clinical syndromes and infections caused by
pathogens that can be acquired and transmitted through
sexual activity (CDC)
• Have significant health social and economic consequences
• Among the health impacts – cervical cancer, PID, infertility,
ectopic pregnancy, CPP, congenital syphilis, neonatal
conjuctivitis and pneumonia
• Social and economic impacts – marital dysharmony, cost
Epidemiology
• More than 1 million STIs are acquired every day worldwide
• The largest number of new infections occur in regions of
south and south east Asia (45.6%) followed by Sub Saharan
Africa (19.7%).
• In developing countries STDs accounted 8.9% of disease
burden in reproductive aged women excluding HIV
• There is limited data on the prevalence of STIs in Ethiopia
– EDHS 2011 – 1% for each men and women
Effect of HIV and STDs on eachother
• Described as epidemiological synergy
– Both share the same risk factors
• STIs enhance the transmission and acquisition of HIV
infection
– Ulcer diseases disrupt the biological barrier
– Inflammatory STIs produce a weak barrier for HIV
– STIs increase HIV viral shading
– Effective treatment of STIs reduce HIV transmission

• HIV infection changes antimicrobial susceptibility of STI
pathogens
• HIV infection increases susceptibility for STIs
• HIV causes atypical presentation of most STIs
– Persistent and sever herpetic lesions
– Syphilis rapidly progresses to neurosyphilis
• HIV infection is associated with increased chance of
treatment failure in most STIs
Classification of STDs
• Based on their clinical presentation: syndromes
– Ulcerative diseases: syphilis, herpes, chancroid, donovanosis …
– Vaginal discharge: ghonococcus, clamydia, …
– Inguinal bubos: LGV …
– Lower abdominal pain:
– Utrethral discharge:
– Scrotal swelling:
– Neonatal conjuctivitis:
Clinical Diagnosis and Evaluation
• History and physical examination
– Symptoms – based on the syndromes and characterization
– STD risk assessment
• Behavioral risk: sexual behavior
• Biologic risk: HIV infection
– Sexual history:
• Respectful, compassionate and non judgmental
• Use open ended questions
• Normalizing language
• The 5 P’s approach: partner, practice, prevention of pregnancy, protection for STD,
and past history of STD

• Examination
– General examination
– Abdominal examination – tenderness, guarding, mass
– Pelvic examination –
• External genital examination:
• Speculum examination and discharge sampling
• Bimanual examination
• Femoral and inguinal node examination
• Diagnostic tests
– Guided by the type of syndrome and presentation and presence of complications

• Genital ulcer disease:
Genital HSV infection
– Chronic life-long infection
– HSV-1 and HSV-2 can cause genital herpes
– Diagnosis: painful multiple vesicles that ulcerate and crust
• Virologic tests: cell culture and PCR,
• Tzanck preparation – insensitive and nonspecific
• Type specific serologic tests

– Antiviral treatment does not eradicate the virus but effective for:
• 1st episode of infection
• Recurrent episodes
• Frequent attacks - as a suppressive therapy
– Reduce recurrence by 70-80%
• IV antivirals for severe disease
– Partner treatment
• Evaluation and counseling, treat symptomatic disease
– Pregnancy
• Transmission to the new born with active disease near delivery 30-50%

Syphilis
– A systemic diseases caused by Treponema Pallidum
– Clinical stages:
• Primary syphilis: painless genital ulcer with raised round borders
• Secondary syphilis: mucocutaneous lesion – condylomata lata
• Tertiary syphilis: cardiovascular, CNS and muskulosckeletal
• Latent syphilis: lack of clinical symptoms; early and late
• Neurosyphilis: involvement of CNS at any stage

– Diagnosis depends on the stage of the disease
• Primary syphilis: dark field examination
• Secondary syphilis: typical mucocutaneous rash, dark field
examination
• Latent syphilis: serology
– Non-treponemal: VDRL and RPR - screening
– Treponemal: FTA-ABS and TP-PA - diagnosis
• Tertiary syphilis: serology tests
• Neurosyphilis: CSF analysis – cell count and VDRL

– Treatment also depends on the stage
• Primary, secondary and early latent:
– Benzanthine penicilline im 2.4 mIU stat
• Late latent and Tertiary syphilis: same dose weekly for 3 weeks
• Neurosyphilis: aquous crystaline penicilline 3-4 mU Q4 hr for 10-14 days
– Partner treatment: for 1o, 2o and early latent
• Clinical evaluation, serology and treatment
• Within 90 days – presumptive treatment for early syphilis
• > 90 days – presumptive treatment if serology positive or not available

– Follow-up
• Clinical and serologic evaluation at 6 and 12 months
– Additional at 24 months for latent syphilis
– CSF cell count every 6 month for neurosyphilis untill normal
• Treatment failure:
– Persistent signs and symptoms
– 4x increase in non treponemal titer for 2 weeks
– Failure of non-treponemal test to decline 4x in 6-12 months
– Failure of CSF cell count to decrease at 6 month or normal at 2 years
– Retreatment: Benzanthine penicilline 2.4mIU im weekly for 3 weeks

Granuloma Inguinale (Donovanosis)
– Caused by gram negative intracellular bacteria called Klebsiella
granulomatis (Calymmatobacterium granulomatis)
– Painless slowly progressive ulcers with subcutaneous granulomas
(pseudobubos) and no inguinal lymphadenopathies
– Diagnosis is on clinical appearance and Donovan bodies on biopsy
– Treatment: Azithromycine 1g weekly or 500mg daily at least 3
weeks; alternative Doxycycline 100mg bid for 3 weeks
– Partner treatment: examine and treat if contact in the past 60 days

Lymphogranuloma venereum (LGV)
– Caused by Clamydia Trachomatis serobars L1-3
– Characterized by self limited ulcer with tender inguinal and femoral
lymphadenopathy (groove sign)
– Rectal exposure can lead to proctocolitis
– Diagnosis: clinical suspicion and exclusion of other causes
– Treatment: Doxycycline 100 mg po BID for 21 days
– Partner treatment: evaluated and presumptive treatment

Chancroid:
– Caused by Hemophilius Ducreyi
– Less common
– Diagnosis is based on painful gegnital ulcers with inguinal
lymphadenopathy
– Definitive diagnosis need a special culture media
– Should exclude herpes and syhilis
– Treatment is Azithromycine 1g oral, or Ceftriaxone 250mg im single
dose or Erythromycine base 500 mg po QID for 7 days

• Vaginal discharge syndrome
– Can be caused either by vaginitis or cervicitis
– Cervicitis is infection of the columnar endocervical epithelium
– Major diagnostic signs: mucopurulent discharge, endocervical
bleeding; leukorrhea (>10 WBCs/hpf) can be supportive
– It is typically caused by C. Trachomatis or N. Gonorrheae
– Vaginitis is infection and inflammation of the vaginal epithelium
– Typically caused by Bacterial vaginosis, T. Vaginalis and Candidiasis

Chlamydial infection
– The most common infection
– Asymptomatic infection is common – screening
– Have serious sequelae - PID, ectopic pregnancy, infertility
– Diagnosis: cervicitis, NAATs
– Treatment: Azithromycine 1g stat (DOT), Doxycycline for 7 days
– Partner treatment: in the past 60 days
• evaluation and presumptive treatment
– Pregnancy: doxycycline is contraindicated

Gonococcal Infection
– The second most common communicable disease
– Caused by N. Gonorrheae
– Presents with cervicitis but can be asymptomatic in women
– Diagnosis: culture and NAATs; gram staining – diagnostic but …
– Treatment: dual therapy – antimicrobial resistance
• Ceftriaxone 250mg im stat plus Azithromycine 1g po stat
– Partner therapy: in the last 60 days or most recent
• Presumptive dual treatment

Trichomoniasis
– The most common non-viral STI
– Caused by the protozoa Trichomonas Vaginalis
– Most persons have minimal or no symptoms - vaginitis
– Associated with increased risk of HIV transmission, preterm birth
– Diagnosis: NAATs, wet mount (poor sensitivity, low cost)
– Treatment: Metromidazole 2g or Tinidazole 2g po stat
– Partner treatment: current partners – presumptive therapy (EPT)

Bacterial vaginosis
– A polymicrobial clinical syndrome
– The most prevalent cause of vaginal discharge
– Caused by replacement of Lactobacillus spp. by anaerobic bacteria
– Risk factors: multiple sexual partners … , douching, lack of
Lactobacilli …
– Women with no sexual activity can rarely be affected.
– Increases risk of HIV acquisition and transmission, surgical site
infections following gynecologic surgery, preterm delivery …

– Diagnosis: clinical criteria – Amsel’s criteria or gram staining
• Amsel’s criteria – 3 of 4 criteria
– Homogeneous, thin discharge coating the vagina
– Clue cells on microscopy (at least 20%)
– Vaginal pH >4.5
– Fishy odor with or without KOH (whiff test)
• Gram stain (Nugent Score)– determine relative concentration of
lactobacilli
– Treatment: recommended for symptoms
• Metronidazole 500mg po bid for 7 days

Vulvovaginal Candidiasis
– Caused by C. albicans and other candida species
– Symptoms include pruritis, vaginal soarness, dyspareunia, external
dysuria, and thick curdy vaginal discharge.
– More common in obese, diabetic and immun-compromised women
– Uncomplicated VVC: sporadic, mild to moderate, albicans, immun-
competent host
– Complicated VVC: recurrent, severe, non-albican and immun-
compromised host

– Recurrent VVC is defined by 4 or more episodes per year
– Diagnosis: symptoms and culture / wet mount (KOH) / Gram stain
• Candida infection is associated with normal pH (<4.5)
• Culture is needed for complicated VVC
– Treatment: antifungals
• Uncomplicated VVC – Short course topical antifungals (1 – 3 days)
• Recurrent VVC – topical antifungal (7 – 14 days) or oral fluconazole
• Maintainance - oral fluconazole
Prevention and control of STDs
• Five major strategies:
– Accurate risk assessment, education and counseling
– Pre-exposure vaccination of vaccine preventable STDs
– Identification of asymptomatic and symptomatic persons
– Effective diagnosis, treatment, counseling and follow up of infected
persons
– Evaluation, treatment and counseling of sex partners

• Primary prevention
– Abstinence
– Correct and consistent use of condom
– Safe sex practice
– Mutual monogamy
– Pre-exposure vaccination
• Secondary prevention
– Promoting STI care seeking behavior
– Early diagnosis and treatment
– Case finding and screening – including partner notification
Management Approaches for STDs
• Three approaches:
Clinical – use clinical experience to identify etiology and treat
– Advantage: Saves time, reduces lab. Expense
– Disadvantage: high clinical skill, mixed and asymptomatic missed
Etiologic – use laboratory tests to isolate and treat the etiology
– Advantage: avoids over treatment, used for screening
– Disadvantage: expensive, time consuming, not suitable primary
health care, mixed infections can be missed

Syndromic – identify syndromes and treat all possible etiologies
– Advantages: simple, rapid , inexpensive, mixed infections are
addressed, avoids unnecessary referrals, can be completed with
one visit
– Disadvantages: over treatment, requires prior epidemiologic
knowledge, asymptomatic infections are missed, low specificity for
cervical infections
– Uses flowcharts (algorithms): components
• The clinical problem, the decision and the action


• Syndromic management of genital ulcer disease

• Syndromic management of vaginal discharge syndrome
Pelvic Inflammatory Disease
• PID is infection of the upper female genital organs
– endometritis, salpingitis, tubo-ovarian abscess and pelvic peritonitis
• Most cases are initiated by sexually transmitted organisms
– Ascending infection
• Gonococcus, chlamydia, T. vaginalis …
• Some cases can be by blood born pathogens
– Pelvic tuberculosis

• Diagnosis
– Can be acute PID, Silent PID and chronic PID
Silent PID – asymptomatic continuous low grade infection
– Diagnosed as tubal factor infertility with grossly normal tubes
Acute PID – symptomatic
– Symptoms usually develop following mensus.
– Lower abdominal/pelvic pain, vaginal discharge (mucopurulent
cervicitis), and systemic symptoms
– On examination there will be lower abdominal/pelvic tenderness

– Presumptive diagnosis – one major and one minor criteria
– High index of suspicion is important
• Major – uterine, adnexal or cervical motion tenderness
• Minor –
– Fever
– Muco-purulent vaginal discharge
– Leukorrhea on microscopy
– Elevated ESR or C-RP
– Cervical gonococcal or chlamydial infection

– Diagnostic testing: confirming diagnosis and excluding differentials
• Urine hCG
• CBC
• Urine analysis
• Cervical swab
• Screening for STDs
• Endometrial biopsy
• Ultrasound – hydrosalpinx and excluding other causes
• Laparoscopy – definitive diagnosis

Chronic PID
– Clinical utility is limited
– Diagnosed with a history of acute PID and chronic pelvic pain
– Hydrosalpinx may indicate chronic PID
Tubo-ovarian abscess
– PID is an important cause – appendicitis, diverticulitis, surgery …
– Present with signs of PID and cul-de-sac or adnexal complex mass

• Treatment
– Goal of treatment is to alleviate symptoms and prevent sequelae
– Presumptive treatment is recommended on clinical diagnosis
Out patient or Oral treatment
– Mild to moderate symptoms
– Regimen:
• Ceftriaxone 250mg IM stat + Doxycycline 100 mg PO BID for 14 days
• With or without Metronidazole 500mg PO BID for 14 days
– Reevaluate after 72 hours

Hospitalization or Parentral treatment
– Criteria:
• Pregnancy, adolescent
• Severe disease (temp.>38.3oC, WBC >15,000/mm3)
• Suspected TOA or generalized peritonitis
• Uncertain diagnosis
• Failed or intolerance to outpatient treatment
– Regimen:
• Cefotetan or cefoxitine + Doxycycline po/iv OR
• Clindamycine + Gentamicine iv

Tubo-ovarian abscess
– Treated as PID with parentral antibiotics
– Treatment continued for 24 hours after afebrile (48 -72 hours)
– Transition to oral therapy – doxycycline with metronidazole or
clindamycin for 14 days
– Surgical drainage – consider
• Initially if size is >8cm
• Rupture of abscess
• No improvement after 48 -72 hours

• Syndromic management of lower abdominal pain syndrome

You might also like